Skip to content

Cancer Health Center

Medical Reference Related to Cancer

  1. Delirium (PDQ®): Supportive care - Health Professional Information [NCI] - Changes to This Summary (07 / 30 / 2014)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.This summary was extensively revised and renamed from Cognitive Disorders and Delirium.This summary is written and maintained by the PDQ Supportive and Palliative Care Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.

  2. Colon Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - General Information About Colon Cancer

    Related Summaries Note: Other PDQ summaries containing information related to colon cancer include the following: Colorectal Cancer Screening Colorectal Cancer Prevention Genetics of Colorectal Cancer Unusual Cancers of Childhood Treatment (childhood cancer of the colon) Statistics Note: Estimated new cases and deaths from colon cancer in the United States in 2010:[ 1 ] New cases: 102,900 (colon ...

  3. Levels of Evidence for Cancer Genetics Studies (PDQ®): Genetics - Health Professional Information [NCI] - Clinical Validity

    Clinical validity refers to the predictive value of a test for a given clinical outcome (e.g., the likelihood that cancer will develop in someone with a positive test). It is primarily determined by the sensitivity and specificity with which a test identifies people with a defined clinical condition within a given population. Sensitivity of a test refers to the proportion of people who test positive for a clinical condition among those who actually have the clinical condition; specificity refers to the proportion of people who test negative for a clinical condition among those who do not have the clinical condition. In the case of genetic susceptibility to cancer, clinical validity can be considered at two levels: Does a positive test identify a person as having an increased risk of cancer?If so, how high is the cancer risk associated with a positive test?Thus, the clinical validity of a genetic test is the likelihood that cancer will develop in someone with a positive test result.

  4. Parathyroid Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - To Learn More About Parathyroid Cancer

    For more information from the National Cancer Institute about parathyroid cancer, see the Parathyroid Cancer Home Page.For general cancer information and other resources from the National Cancer Institute, see the following:What You Need to Know About™ CancerUnderstanding Cancer Series: CancerCancer StagingChemotherapy and You: Support for People With CancerRadiation Therapy and You: Support for People With CancerCoping with Cancer: Supportive and Palliative CareQuestions to Ask Your Doctor About CancerCancer LibraryInformation For Survivors/Caregivers/Advocates

  5. Childhood Ependymoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Treatment of Newly Diagnosed Childhood Ependymoma or Anaplastic Ependymoma

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Treatment of Recurrent Childhood EpendymomaAdded Bouffet et al. as reference 8.This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.

  6. Sexuality and Reproductive Issues (PDQ®): Supportive care - Patient Information [NCI] - Questions or Comments About This Summary

    About PDQPhysician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in Spanish.PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government's center of biomedical research. The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.Purpose of This SummaryThis PDQ cancer information summary has current

  7. Childhood Soft Tissue Sarcoma Treatment (PDQ®): Treatment - Patient Information [NCI] - About This PDQ Summary

    About PDQPhysician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in Spanish.PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government's center of biomedical research. The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.Purpose of This SummaryThis PDQ cancer information summary has current

  8. Neuroblastoma Treatment (PDQ®): Treatment - Patient Information [NCI] - About This PDQ Summary

    About PDQPhysician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in Spanish.PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government's center of biomedical research. The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.Purpose of This SummaryThis PDQ cancer information summary has current

  9. Levels of Evidence for Cancer Screening and Prevention Studies (PDQ®): Screening - Health Professional Information [NCI] - Introduction

    The Levels of Evidence for the Screening and Prevention statements are being revised. This document is a work in progress. To date,these Levels of Evidence have been applied to the following Screening and Prevention statements: Screening for Bladder and Other Urothelial Cancers; Screening for Cervical Cancer; Screening for Esophageal Cancer; Screening for Gastric Cancer; Screening for Lung ...

  10. Childhood Rhabdomyosarcoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Changes to This Summary (08 / 19 / 2014)

    The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Stage InformationAdded Federico et al. as reference 4.Recurrent Childhood RhabdomyosarcomaAdded text to state that a retrospective analysis of children with recurrence after initial presentation with localized rhabdomyosarcoma of the orbit reported 80% survival 5 years after recurrence with aggressive retrieval therapy (cited Raney et al. as reference 4 and level of evidence 3iiA).Added text to state that in a phase II study in France (N = 50), children with recurrent or refractory rhabdomyosarcoma were treated with vinorelbine and low-dose oral cyclophosphamide; 4 complete responses and 14 partial responses were observed, for an objective response rate of 36% (cited Minard-Colin et al. as reference 21 and level of evidence 3iiiDiv).This summary is written and maintained by the PDQ Pediatric

Displaying 121 - 130 of 4776 Articles << Prev Page 9 10 11 12 13 14 15 16 17 18 Next >>

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
 
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
 
Jennifer Goodman Linn self-portrait
Blog
what is your cancer risk
HEALTH CHECK
 
colorectal cancer treatment advances
Video
breast cancer overview slideshow
SLIDESHOW
 
prostate cancer overview
SLIDESHOW
lung cancer overview slideshow
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
Actor Michael Douglas
Article